Does PEMBROLIZUMAB Cause Sinus tachycardia? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Sinus tachycardia have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
68
Reports of Sinus tachycardia with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
6
Deaths
35
Hospitalizations
How Dangerous Is Sinus tachycardia From PEMBROLIZUMAB?
Of the 68 reports, 6 (8.8%) resulted in death, 35 (51.5%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Sinus tachycardia Listed in the Official Label?
Yes, Sinus tachycardia is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Sinus tachycardia?
CLOZAPINE (598)
QUETIAPINE (593)
BUPROPION (311)
OLANZAPINE (296)
ACETAMINOPHEN (267)
VENLAFAXINE (263)
CYCLOPHOSPHAMIDE (247)
RISPERIDONE (244)
ARIPIPRAZOLE (236)
AMLODIPINE (228)
Which PEMBROLIZUMAB Alternatives Have Lower Sinus tachycardia Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G